SOD2 and cardiac hypertrophy: SIRT3 was previously demonstrated to counteract cardiac hypertrophy in primary cultures of cardiomyocytes by activating MnSOD and catalase, thereby decreasing cellular levels of ROS, suppressing Ras activation and the downstream signaling pathway through the MAPK/ERK and PI3K/Akt pathways.